Who has invested in Artax Biopharma?

Lilly, Advent Life Sciences, Columbus Venture Partners are named among the investors backing Artax Biopharma.

Artax Biopharma Funding: $26M Raised, Series A (2024)

Artax Biopharma funding overview

Artax Biopharma is based in Cambridge, MA. Artax Biopharma has raised $26M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in August 2024. The round record for Artax Biopharma runs through 2024; nothing later has been disclosed. Investors on record include Lilly, Advent Life Sciences, Columbus Venture Partners. 3 distinct backers are named across the disclosed rounds.

Artax Biopharma at a glance

Total raised: $26M
Latest round: Series A
Latest round date: August 2024
Headquarters: Cambridge, MA
Notable investors: Lilly, Advent Life Sciences, Columbus Venture Partners

Frequently asked about Artax Biopharma funding

How much has Artax Biopharma raised?: Artax Biopharma has raised $26M in total disclosed funding across the rounds on record.
Who has invested in Artax Biopharma?: Lilly, Advent Life Sciences, Columbus Venture Partners are named among the investors backing Artax Biopharma.
What was the latest Artax Biopharma funding round?: The most recent disclosed round is a Series A, announced in August 2024.
Where is Artax Biopharma based?: Artax Biopharma is based in Cambridge, MA.
When did Artax Biopharma last raise?: The last disclosed Artax Biopharma round closed in August 2024 at Series A.

Round data for Artax Biopharma is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Cambridge and backer lists below.

Artax Biopharma Funding: $26M Raised, Series A (2024)

Artax Biopharma funding overview

Artax Biopharma at a glance

Frequently asked about Artax Biopharma funding

Companies related to Artax Biopharma (23)

Browse related funding lists (6)